GLP-1 and its receptor agonists have been shown to reduce endothelial inflammation and oxidative stress, through the activation of nitric oxide production, crucial for maintaining healthy vascular tone and function ( Incretin-based therapies has evidenced a reduced cardiovascular risk in high-risk individuals with type 2 diabetes, independent of the need for additional glucose control
Epigenetic factors, including DNA methylation, histone modifications, and microRNAs, further modulate BCMO1 expression, influenced by diet, inflammation, and stress [22]
In simpler terms, it works by: Significantly reducing appetite and cravings through central action in the brain
Similar to the transcriptomic changes observed in the hypothalamus, we found that the conjugate prompted transcriptional patterns enriched for functional terms associated with synaptic transmission, including postsynaptic specialization and neuron-to-neuron synapse in the brainstem (Extended Data Fig